Active

D2S Pharma

Switched

BE0563446868

Rechtspersoon Private limited company 1 establishment

Berchemweg 139, 9700 Oudenaarde Vervaardiging van farmaceutische grondstoffen

Active for

11 year, 11 months

Financials

Financial year 2025

Gross margin

€ 129,195

▲ 16% vs 2024

Profit

Growing

€ 38,474

▲ 117% vs 2024

Debts

Low

€ 157,621

▲ 5% vs 2024

D2S Pharma from Oudenaarde, company number BE0563446868, closed financial year 2025 with a result of € 38,474 after tax. For that financial year D2S Pharma recorded a gross margin of € 129,195 and equity of € 424,697. Compared with financial year 2024, the result moved from € 17,705 to € 38,474. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 20, 2026.

What happened at D2S Pharma?

What happened at D2S Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 38,474 (▲ 117% vs 2024). filed late Source: NBB ↗
  • New establishment in Oudenaarde. KBO
  • Start of the company according to the CBE. KBO

In short

From € 12,312 profit in 2022 to € 38,474 profit in 2025.

Paid € 27,191 in corporate taxes since 2022.

Best year ever: 2025, with € 38,474 profit.

A new publication or filing at D2S Pharma? We notify you, reason included.

Follow D2S Pharma

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

D2S Pharma

Behind D2S Pharma is Lumadec BV. Lumadec BV is also behind CARUUR.

See the full network in the app

Directors

According to the 2025 annual accounts

Lumadec BV

Director · represented by Luc Deconinck

Also active at: CARUUR

Establishments

Establishment units

Physical locations of this company

Registered office

Berchemweg 139

9700 Oudenaarde

2.235.656.394

Paalstraat 16

9700 Oudenaarde

Active since 30 September 2014

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0563.446.868
VAT number
BE 0563.446.868
Registered office
Berchemweg 139, 9700 Oudenaarde
Names & denominations
D2S Pharma
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
30 September 2014
Peppol
Active · Active since 12 Dec 2025
Activities · NACE

Vervaardiging van farmaceutische grondstoffen

Vervaardiging van parfums en toiletartikelen

Groothandel in farmaceutische en medische artikelen

Overige zakelijke dienstverlening, neg

Frequently asked questions

What is the enterprise number of D2S Pharma?
The enterprise number of D2S Pharma is BE0563446868.
What is the address of D2S Pharma?
The registered office of D2S Pharma is located at Berchemweg 139, 9700 Oudenaarde.
When was D2S Pharma founded?
D2S Pharma was founded on 30 September 2014.
What is the main activity of D2S Pharma?
The main activity of D2S Pharma is "Vervaardiging van farmaceutische grondstoffen" (NACE code 21100).
Does D2S Pharma have a website?
No website is currently known for D2S Pharma.
How much profit did D2S Pharma make in 2025?
D2S Pharma posted a profit after taxes of € 38,474 in financial year 2025.
What is the revenue of D2S Pharma?
As a small company, D2S Pharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 129,195.
How many employees does D2S Pharma have?
According to the 2025 annual accounts, D2S Pharma has 0.5 full-time equivalents (FTE).
Where can I find the annual accounts of D2S Pharma?
D2S Pharma files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of D2S Pharma?
According to the 2025 annual accounts, the directors of D2S Pharma are: Lumadec BV.
Who owns D2S Pharma?
Behind D2S Pharma is Lumadec BV. Lumadec BV is also behind CARUUR.